Yvette van Kooyk

Author PubWeight™ 137.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007 4.20
2 The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002 3.48
3 C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002 3.44
4 C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007 3.32
5 Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005 2.70
6 S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 2008 2.65
7 Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 2004 2.62
8 Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003 2.39
9 DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med 2004 2.38
10 Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med 2005 2.12
11 Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 2004 2.08
12 Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol Immunol 2007 1.98
13 The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 2003 1.81
14 Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J Biol Chem 2002 1.71
15 Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 2002 1.67
16 Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol 2012 1.66
17 HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 2002 1.62
18 Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 2002 1.60
19 Innate signaling and regulation of Dendritic cell immunity. Curr Opin Immunol 2007 1.41
20 Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol 2003 1.41
21 Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J Virol 2004 1.37
22 Close encounters of neutrophils and DCs. Trends Immunol 2005 1.36
23 Glycobiology of immune responses. Ann N Y Acad Sci 2012 1.36
24 Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res 2006 1.35
25 Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses. Immunol Cell Biol 2008 1.35
26 Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins. J Immunol 2007 1.34
27 Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur J Immunol 2003 1.33
28 Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006 1.32
29 Immune escape through C-type lectins on dendritic cells. Trends Immunol 2002 1.30
30 Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol 2006 1.26
31 Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. Int Immunol 2005 1.23
32 Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus. PLoS Pathog 2011 1.23
33 Sweet preferences of MGL: carbohydrate specificity and function. Trends Immunol 2008 1.20
34 Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction. J Virol 2005 1.19
35 Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am J Pathol 2004 1.16
36 Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res 2005 1.16
37 Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils. FEBS Lett 2005 1.15
38 The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol Immunother 2006 1.14
39 TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol 2010 1.14
40 Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J Gen Virol 2008 1.12
41 Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 2004 1.12
42 Variation of Neisseria gonorrhoeae lipooligosaccharide directs dendritic cell-induced T helper responses. PLoS Pathog 2009 1.12
43 Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol Immunol 2009 1.09
44 Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol Rev 2009 1.09
45 Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell Microbiol 2005 1.09
46 Intercellular adhesion molecule-1/LFA-1 ligation favors human Th1 development. J Immunol 2002 1.08
47 Recognition of tumor glycans by antigen-presenting cells. Curr Opin Immunol 2005 1.08
48 Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function. Cell Microbiol 2006 1.08
49 Two distinct cytoplasmic regions of the beta2 integrin chain regulate RhoA function during phagocytosis. J Cell Biol 2006 1.07
50 Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun 2011 1.06
51 Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol 2004 1.06
52 MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol Immunol 2009 1.06
53 N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell Microbiol 2009 1.05
54 Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection. Eur J Immunol 2005 1.05
55 The physiological role of DC-SIGN: a tale of mice and men. Trends Immunol 2013 1.05
56 Targeting tumor antigens to dendritic cells using particulate carriers. J Control Release 2012 1.05
57 Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 2003 1.04
58 Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol 2004 1.04
59 Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1. Immunobiology 2004 1.04
60 Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. Microbes Infect 2006 1.04
61 Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. J Control Release 2012 1.02
62 Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat Rev Microbiol 2006 1.02
63 Schistosoma mansoni worm glycolipids induce an inflammatory phenotype in human dendritic cells by cooperation of TLR4 and DC-SIGN. Mol Immunol 2010 1.02
64 Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients. Int J Cancer 2011 1.01
65 DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN. J Biol Chem 2005 1.00
66 Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae. Mol Immunol 2008 0.97
67 DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2. Mol Immunol 2007 0.97
68 Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells. PLoS One 2009 0.96
69 Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties. Mol Immunol 2009 0.95
70 'Dressed for success' C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells. Curr Opin Immunol 2010 0.95
71 Skin-resident antigen-presenting cells: instruction manual for vaccine development. Front Immunol 2013 0.94
72 Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming. Eur J Immunol 2014 0.94
73 TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol 2009 0.94
74 Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans. J Immunol 2013 0.93
75 Designing polymeric particles for antigen delivery. Chem Soc Rev 2010 0.93
76 Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology 2006 0.92
77 Two way communication between neutrophils and dendritic cells. Curr Opin Pharmacol 2006 0.91
78 Vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) provide co-stimulation in positive selection along with survival of selected thymocytes. Mol Immunol 2007 0.91
79 Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization. Eur J Immunol 2011 0.90
80 MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion. J Leukoc Biol 2013 0.90
81 Notch controls generation and function of human effector CD8+ T cells. Blood 2013 0.90
82 One-step biotinylation procedure for carbohydrates to study carbohydrate-protein interactions. Anal Biochem 2006 0.89
83 Specific glycan elements determine differential binding of individual egg glycoproteins of the human parasite Schistosoma mansoni by host C-type lectin receptors. Int J Parasitol 2012 0.89
84 The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs. J Immunol 2008 0.89
85 MGL-mediated internalization and antigen presentation by dendritic cells: a role for tyrosine-5. Eur J Immunol 2007 0.89
86 DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14. Immunobiology 2005 0.89
87 Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1. Blood 2002 0.88
88 Yin-Yang regulation of autoimmunity by DCs. Trends Immunol 2004 0.87
89 Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses. Int J Cancer 2011 0.87
90 Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120. Virology 2004 0.86
91 Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells. Int J Cancer 2008 0.86
92 Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain. PLoS One 2013 0.85
93 Online nanoliquid chromatography-mass spectrometry and nanofluorescence detection for high-resolution quantitative N-glycan analysis. Anal Biochem 2012 0.84
94 Molecular mechanisms that set the stage for DC-T cell engagement. Immunol Lett 2004 0.84
95 Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation. Immunobiology 2007 0.84
96 In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity. Eur J Immunol 2013 0.82
97 Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells. Int Immunol 2013 0.82
98 Intestinal epithelium-derived galectin-9 is involved in the immunomodulating effects of nondigestible oligosaccharides. J Innate Immun 2013 0.81
99 Human T cell activation results in extracellular signal-regulated kinase (ERK)-calcineurin-dependent exposure of Tn antigen on the cell surface and binding of the macrophage galactose-type lectin (MGL). J Biol Chem 2013 0.81
100 The glycosylation of thymic microenvironments. A microscopic study using plant lectins. Immunol Lett 2007 0.81
101 DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations. Int J Pharm 2011 0.81
102 BODIPY-labeled DC-SIGN-targeting glycodendrons efficiently internalize and route to lysosomes in human dendritic cells. Biomacromolecules 2012 0.79
103 Identification of pathogen receptors on dendritic cells to understand their function and to identify new drug targets. Methods Mol Biol 2009 0.79
104 Carbohydrate specificities of the murine DC-SIGN homologue mSIGNR1. Immunobiology 2005 0.79
105 Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles. Bioconjug Chem 2014 0.78
106 Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines. Oncoimmunology 2013 0.78
107 Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses. Eur J Immunol 2015 0.78
108 Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells. Front Immunol 2013 0.78
109 Regulation of LFA-1 Expression by CD34 Positive Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments; Subject Heading. Hematology 2000 0.78
110 Highly glycosylated tumour antigens: interactions with the immune system. Biochem Soc Trans 2011 0.78
111 Activation of human monocyte-derived dendritic cells by Burkholderia pseudomallei does not require binding to the C-type lectin DC-SIGN. Trans R Soc Trop Med Hyg 2008 0.77
112 Enhanced glycan nanoprofiling by weak anion exchange preparative chromatography, mild acid desialylation, and nanoliquid chromatography-mass spectrometry with nanofluorescence detection. Electrophoresis 2013 0.77
113 Leptospira interrogans is recognized through DC-SIGN and induces maturation and cytokine production by human dendritic cells. FEMS Immunol Med Microbiol 2008 0.76
114 Effects of antigen-expressing immunostimulatory liposomes on chemotaxis and maturation of dendritic cells in vitro and in human skin explants. Pharm Res 2013 0.75
115 State of the union: glycobiology and immunology in the Canadian Rockies. Glycobiology 2011 0.75
116 The Human Glycoprotein Salivary Agglutinin Inhibits the Interaction of DC-SIGN and Langerin with Oral Micro-Organisms. J Innate Immun 2016 0.75